#9: TheMachine: AMLY Stock News : Eastbourne Calls on Amylin Employees to Help Shape the Company’s Future and Support Change to the Board
Urges Them to Vote the WHITE Proxy Card and Elect All Three of Its
... |
May 25, 2009
11:49:38 PM |
#8: TheMachine: Amylin Pharmaceuticals Reports First Quarter Financial Results
SAN DIEGO, April 21 /PRNewswire-FirstCall/ --... |
April 23, 2008
12:56:12 AM |
#7: FastFun: Amylin Pharmaceuticals to Present at Research & Development Day
SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,... |
November 28, 2007
09:36:33 PM |
#6: FastFun: Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study
Findings validate novel integrated neurohormonal treatment of obesity... |
November 28, 2007
09:33:29 PM |
#5: FastFun: Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
- Both Groups Experienced Significant Weight Loss -
- New Drug... |
November 28, 2007
09:32:48 PM |
#4: FastFun: Amylin Pharmaceuticals to Webcast Third Quarter Results and Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B
Biotechnology industry alert provided by U.S. Equity News. Amylin... |
October 17, 2007
09:27:43 AM |
#3: FastFun: Amylin Pharmaceuticals to Webcast Third Quarter Results
SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,... |
October 17, 2007
09:27:07 AM |
#2: FastFun: Medarex to Present at the Natixis Bleichroeder's Hidden Gems Conference and Amylin Pharma OK's Symlin Pen-Injector Devices
Biotechnology industry alert provided by U.S. Equity News. Medarex, Inc.... |
October 17, 2007
09:25:55 AM |
#1: Stock News Bot: AMLN News Once Weekly Exenatide LAR Well Tolerated and Improved Glucose Control; Preliminary Results From Phase 2 Study Announced
SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 22,... |
August 22, 2005
09:30:00 AM |
